{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T00:29:22Z","timestamp":1790296162722,"version":"4.1.0"},"reference-count":33,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2024,8,28]],"date-time":"2024-08-28T00:00:00Z","timestamp":1724803200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,8,28]],"date-time":"2024-08-28T00:00:00Z","timestamp":1724803200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Rheumatol Int"],"DOI":"10.1007\/s00296-024-05703-4","type":"journal-article","created":{"date-parts":[[2024,8,28]],"date-time":"2024-08-28T15:02:06Z","timestamp":1724857326000},"page":"2197-2203","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Postpartum onset anti-MDA5 antibody-positive clinically amyopathic dermatomyositis; case-based review of perinatal onset anti-MDA5 antibody-positive dermatomyositis"],"prefix":"10.1007","volume":"44","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2793-5589","authenticated-orcid":false,"given":"Saori","family":"Abe","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9067-0961","authenticated-orcid":false,"given":"Hiroto","family":"Tsuboi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0003-7869-9528","authenticated-orcid":false,"given":"Hirofumi","family":"Toko","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0006-7268-1724","authenticated-orcid":false,"given":"Mizuki","family":"Yagishita","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0007-9105-5806","authenticated-orcid":false,"given":"Ayako","family":"Ohyama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8031-7718","authenticated-orcid":false,"given":"Ayako","family":"Kitada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9435-2917","authenticated-orcid":false,"given":"Haruka","family":"Miki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0006-9085-9696","authenticated-orcid":false,"given":"Hiromitsu","family":"Asashima","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1708-4402","authenticated-orcid":false,"given":"Yuya","family":"Kondo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7995-9294","authenticated-orcid":false,"given":"Isao","family":"Matsumoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,8,28]]},"reference":[{"issue":"5","key":"5703_CR1","doi-asserted-by":"publisher","first-page":"290","DOI":"10.1038\/nrrheum.2018.56","volume":"14","author":"NJ McHugh","year":"2018","unstructured":"McHugh NJ, Tansley SL (2018) Autoantibodies in myositis. Nat Rev Rheumatol 14(5):290\u20133022. https:\/\/doi.org\/10.1038\/nrrheum.2018.56","journal-title":"Nat Rev Rheumatol"},{"issue":"1","key":"5703_CR2","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1038\/s41584-023-01054-9","volume":"20","author":"X Lu","year":"2024","unstructured":"Lu X, Peng Q, Wang G (2024) Anti-MDA5 antibody-positive dermatomyositis: pathogenesis and clinical progress. Nat Rev Rheumatol 20(1):48\u201362. https:\/\/doi.org\/10.1038\/s41584-023-01054-9","journal-title":"Nat Rev Rheumatol"},{"key":"5703_CR3","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.773352","author":"A Nombel","year":"2021","unstructured":"Nombel A, Fabien N, Coutant F (2021) Dermatomyositis with anti-MDA5 antibodies: bioclinical features, pathogenesis and emerging therapies. Front Immunol. https:\/\/doi.org\/10.3389\/fimmu.2021.773352","journal-title":"Front Immunol"},{"issue":"10","key":"5703_CR4","doi-asserted-by":"publisher","first-page":"4087","DOI":"10.1093\/rheumatology\/keac030","volume":"61","author":"MPM Hensgens","year":"2022","unstructured":"Hensgens MPM, Delemarre EM, Drylewicz J et al (2022) Clinical features and immune-related protein patterns of anti-MDA5 positive clinically amyopathic dermatomyositis Dutch patients. Rheumatology (Oxford) 61(10):4087\u20134096. https:\/\/doi.org\/10.1093\/rheumatology\/keac030","journal-title":"Rheumatology (Oxford)"},{"issue":"6","key":"5703_CR5","doi-asserted-by":"publisher","first-page":"1450","DOI":"10.1093\/rheumatology\/kez527","volume":"59","author":"K Oya","year":"2020","unstructured":"Oya K, Inoue S, Saito A et al (2020) Pregnancy triggers the onset of anti-transcriptional intermediary factor 1\u03b3 antibody-positive dermatomyositis: a case series. Rheumatology (Oxford) 59(6):1450\u20131451. https:\/\/doi.org\/10.1093\/rheumatology\/kez527","journal-title":"Rheumatology (Oxford)"},{"issue":"1","key":"5703_CR6","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1001\/archderm.142.1.70","volume":"142","author":"D Sereda","year":"2006","unstructured":"Sereda D, Werth VP (2006) Improvement in dermatomyositis rash associated with the use of antiestrogen medication. Arch Dermatol 142(1):70\u201372. https:\/\/doi.org\/10.1001\/archderm.142.1.70","journal-title":"Arch Dermatol"},{"issue":"7","key":"5703_CR7","doi-asserted-by":"publisher","first-page":"1271","DOI":"10.1007\/s00296-021-04851-1","volume":"42","author":"C Akiyama","year":"2022","unstructured":"Akiyama C, Shirai T, Sato H, Fujii H, Ishii T, Harigae H (2022) Association of various myositis-specific autoantibodies with dermatomyositis and polymyositis triggered by pregnancy. Rheumatol Int 42(7):1271\u20131280. https:\/\/doi.org\/10.1007\/s00296-021-04851-1","journal-title":"Rheumatol Int"},{"key":"5703_CR8","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.625495","author":"C Chen","year":"2021","unstructured":"Chen C, Chen Y, Huang Q, Hu Q, Hong X (2021) Case report: rapidly progressive interstitial lung disease in a pregnant patient with anti-melanoma differentiation-associated gene 5 antibody-positive dermatomyositis. Front Immunol. https:\/\/doi.org\/10.3389\/fimmu.2021.625495","journal-title":"Front Immunol"},{"key":"5703_CR9","doi-asserted-by":"publisher","DOI":"10.1016\/j.crwh.2023.e00479","author":"H Goto","year":"2023","unstructured":"Goto H, Kawahata K, Shida A et al (2023) Immunosuppressive therapy before and during pregnancy may improve obstetric outcomes in pregnancy complicated by dermatomyositis with anti-MDA-5 antibody positivity: a case report. Case Rep Womens Health. https:\/\/doi.org\/10.1016\/j.crwh.2023.e00479","journal-title":"Case Rep Womens Health"},{"issue":"6","key":"5703_CR10","doi-asserted-by":"publisher","first-page":"1620","DOI":"10.1111\/jog.15625","volume":"49","author":"C Krones","year":"2023","unstructured":"Krones C, Vu M, Popp B, Scardamaglia L (2023) New onset MDA-5 positive dermatomyositis and massive perivillous fibrin deposition in third trimester of pregnancy: a case report. J Obstet Gynaecol Res 49(6):1620\u20131623. https:\/\/doi.org\/10.1111\/jog.15625","journal-title":"J Obstet Gynaecol Res"},{"issue":"2","key":"5703_CR11","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1177\/1753495X20929507","volume":"14","author":"M Alonso-Esp\u00edas","year":"2021","unstructured":"Alonso-Esp\u00edas M, Mart\u00ednez-S\u00e1nchez N, Robles-Marhuenda A, Mart\u00edn-Boado ME, Regojo-Zapata RM, Bartha JL (2021) Diagnosis of amyopathic dermatomyositis after two intrauterine fetal deaths. Obstet Med 14(2):109\u2013112. https:\/\/doi.org\/10.1177\/1753495X20929507","journal-title":"Obstet Med"},{"key":"5703_CR12","doi-asserted-by":"publisher","DOI":"10.3389\/fmed.2021.742823","author":"Q Gu","year":"2021","unstructured":"Gu Q, Diao M, Hu W, Huang M, Zhu Y (2021) Case report: extracorporeal membrane oxygenation for rapidly progressive interstitial lung disease associated with clinically amyopathic dermatomyositis in a post-partum woman. Front Med (Lausanne). https:\/\/doi.org\/10.3389\/fmed.2021.742823","journal-title":"Front Med (Lausanne)"},{"key":"5703_CR13","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaut.2023.103081","author":"RG Kamperman","year":"2023","unstructured":"Kamperman RG, van Leeuwen EM, Willems M et al (2023) Does COVID-19 impact the prevalence of myositis specific antibodies in the Netherlands? A comparative nationwide study. J Autoimmun. https:\/\/doi.org\/10.1016\/j.jaut.2023.103081","journal-title":"J Autoimmun"},{"issue":"1","key":"5703_CR14","doi-asserted-by":"publisher","first-page":"5417","DOI":"10.1038\/s41467-021-25509-3","volume":"12","author":"SE Chang","year":"2021","unstructured":"Chang SE, Feng A, Meng W et al (2021) New-onset IgG autoantibodies in hospitalized patients with COVID-19. Nat Commun 12(1):5417. https:\/\/doi.org\/10.1038\/s41467-021-25509-3","journal-title":"Nat Commun"},{"issue":"11","key":"5703_CR15","doi-asserted-by":"publisher","first-page":"4437","DOI":"10.1093\/rheumatology\/keac094","volume":"61","author":"J So","year":"2022","unstructured":"So J, So H, Wong VT et al (2022) Predictors of rapidly progressive interstitial lung disease and mortality in patients with autoantibodies against melanoma differentiation-associated protein 5 dermatomyositis. Rheumatology (Oxford) 61(11):4437\u20134444. https:\/\/doi.org\/10.1093\/rheumatology\/keac094","journal-title":"Rheumatology (Oxford)"},{"issue":"1","key":"5703_CR16","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1186\/s13075-023-03100-z","volume":"25","author":"H Wang","year":"2023","unstructured":"Wang H, Chen X, Du Y, Wang L, Wang Q, Wu H, Liu L, Xue J (2023) Mortality risk in patients with anti-MDA5 dermatomyositis is related to rapidly progressive interstitial lung disease and anti-Ro52 antibody. Arthritis Res Ther 25(1):127. https:\/\/doi.org\/10.1186\/s13075-023-03100-z","journal-title":"Arthritis Res Ther"},{"issue":"11","key":"5703_CR17","doi-asserted-by":"publisher","first-page":"695","DOI":"10.1038\/s41584-023-01033-0","volume":"19","author":"T Khoo","year":"2023","unstructured":"Khoo T, Lilleker JB, Thong BY, Leclair V, Lamb JA, Chinoy H (2023) Epidemiology of the idiopathic inflammatory myopathies. Nat Rev Rheumatol 19(11):695\u2013712. https:\/\/doi.org\/10.1038\/s41584-023-01033-0","journal-title":"Nat Rev Rheumatol"},{"key":"5703_CR18","doi-asserted-by":"publisher","DOI":"10.1111\/aji.13603","author":"K Tang","year":"2022","unstructured":"Tang K, Zhou J, Lan Y, Zhang H, Jin H (2022) Pregnancy in adult-onset dermatomyositis\/polymyositis: a systematic review. Am J Reprod Immunol. https:\/\/doi.org\/10.1111\/aji.13603","journal-title":"Am J Reprod Immunol"},{"issue":"6","key":"5703_CR19","doi-asserted-by":"publisher","first-page":"865","DOI":"10.1016\/j.semarthrit.2017.11.005","volume":"47","author":"KD Kolstad","year":"2018","unstructured":"Kolstad KD, Fiorentino D, Li S, Chakravarty EF, Chung L (2018) Pregnancy outcomes in adult patients with dermatomyositis and polymyositis. Semin Arthritis Rheum 47(6):865\u2013869. https:\/\/doi.org\/10.1016\/j.semarthrit.2017.11.005","journal-title":"Semin Arthritis Rheum"},{"issue":"5","key":"5703_CR20","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1097\/RHU.0000000000000996","volume":"26","author":"L Gupta","year":"2020","unstructured":"Gupta L, Zanwar A, Ahmed S, Aggarwal A (2020) Outcomes of pregnancy in women with inflammatory myositis: a cohort from India. J Clin Rheumatol 26(5):165\u2013168. https:\/\/doi.org\/10.1097\/RHU.0000000000000996","journal-title":"J Clin Rheumatol"},{"issue":"4","key":"5703_CR21","doi-asserted-by":"publisher","first-page":"609","DOI":"10.1002\/art.42308","volume":"75","author":"L Xu","year":"2023","unstructured":"Xu L, You H, Wang L et al (2023) Identification of three different phenotypes in anti-melanoma differentiation-associated gene 5 antibody-positive dermatomyositis patients: implications for prediction of rapidly progressive interstitial lung disease. Arthritis Rheumatol 75(4):609\u2013619. https:\/\/doi.org\/10.1002\/art.42308","journal-title":"Arthritis Rheumatol"},{"issue":"1","key":"5703_CR22","doi-asserted-by":"publisher","first-page":"e70","DOI":"10.1212\/WNL.0000000000009727","volume":"95","author":"Y Allenbach","year":"2020","unstructured":"Allenbach Y, Uzunhan Y, Toquet S et al (2020) Different phenotypes in dermatomyositis associated with anti-MDA5 antibody: study of 121 cases. Neurology 95(1):e70\u2013e78. https:\/\/doi.org\/10.1212\/WNL.0000000000009727","journal-title":"Neurology"},{"issue":"4","key":"5703_CR23","doi-asserted-by":"publisher","first-page":"677","DOI":"10.1002\/art.41566","volume":"73","author":"T Gono","year":"2021","unstructured":"Gono T, Masui K, Nishina N et al (2021) Risk prediction modeling based on a combination of initial serum biomarker levels in polymyositis\/dermatomyositis-associated interstitial lung disease. Arthritis Rheumatol 73(4):677\u2013686. https:\/\/doi.org\/10.1002\/art.41566","journal-title":"Arthritis Rheumatol"},{"issue":"4","key":"5703_CR24","doi-asserted-by":"publisher","first-page":"1535","DOI":"10.1016\/j.chest.2020.04.057","volume":"158","author":"X Lian","year":"2020","unstructured":"Lian X, Zou J, Guo Q et al (2020) Mortality risk prediction in amyopathic dermatomyositis associated with interstitial lung disease: the FLAIR model. Chest 158(4):1535\u20131545. https:\/\/doi.org\/10.1016\/j.chest.2020.04.057","journal-title":"Chest"},{"issue":"4","key":"5703_CR25","doi-asserted-by":"publisher","first-page":"529","DOI":"10.1016\/j.chest.2020.04.057","volume":"72","author":"LR Sammaritano","year":"2020","unstructured":"Sammaritano LR, Bermas BL, Chakravarty EE et al (2020) 2020 American College of Rheumatology guideline for the management of reproductive health in rheumatic and musculoskeletal diseases. Arthritis Rheumatol 72(4):529\u2013556. https:\/\/doi.org\/10.1016\/j.chest.2020.04.057","journal-title":"Arthritis Rheumatol"},{"issue":"4","key":"5703_CR26","doi-asserted-by":"publisher","first-page":"e48","DOI":"10.1093\/rheumatology\/keac551","volume":"62","author":"MD Russell","year":"2023","unstructured":"Russell MD, Dey M, Flint J et al (2023) British Society for Rheumatology guideline on prescribing drugs in pregnancy and breastfeeding: immunomodulatory anti-rheumatic drugs and corticosteroids. Rheumatology (Oxford) 62(4):e48\u2013e88. https:\/\/doi.org\/10.1093\/rheumatology\/keac551","journal-title":"Rheumatology (Oxford)"},{"issue":"2","key":"5703_CR27","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1038\/s41584-019-0351-2","volume":"16","author":"F F\u00f6rger","year":"2020","unstructured":"F\u00f6rger F, Villiger PM (2020) Immunological adaptations in pregnancy that modulate rheumatoid arthritis disease activity. Nat Rev Rheumatol 16(2):113\u2013122. https:\/\/doi.org\/10.1038\/s41584-019-0351-2","journal-title":"Nat Rev Rheumatol"},{"issue":"3","key":"5703_CR28","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1016\/j.immuni.2018.07.017","volume":"49","author":"LJ Yockey","year":"2018","unstructured":"Yockey LJ, Iwasaki A (2018) Interferons and proinflammatory cytokines in pregnancy and fetal development. Immunity 49(3):397\u2013412","journal-title":"Immunity"},{"issue":"3","key":"5703_CR29","doi-asserted-by":"publisher","first-page":"J287","DOI":"10.1016\/j.jaut.2009.11.015","volume":"34","author":"AT Borchers","year":"2010","unstructured":"Borchers AT, Naguwa SM, Keen CL, Gershwin ME (2010) The implications of autoimmunity and pregnancy. J Autoimmun 34(3):J287\u2013J299","journal-title":"J Autoimmun"},{"issue":"3","key":"5703_CR30","first-page":"2","volume":"47","author":"M Cutolo","year":"2008","unstructured":"Cutolo M, Capellino S, Straub RH (2008) Oestrogens in rheumatic diseases: friend or foe? Rheumatology (Oxford) 47(3):2\u20135","journal-title":"Rheumatology (Oxford)"},{"issue":"11","key":"5703_CR31","doi-asserted-by":"publisher","first-page":"673","DOI":"10.1038\/s41584-019-0307-6","volume":"15","author":"NC Lambert","year":"2019","unstructured":"Lambert NC (2019) Nonendocrine mechanisms of sex bias in rheumatic diseases. Nat Rev Rheumatol 15(11):673\u2013686","journal-title":"Nat Rev Rheumatol"},{"issue":"11","key":"5703_CR32","doi-asserted-by":"publisher","first-page":"3237","DOI":"10.1002\/art.11324","volume":"48","author":"K Khosrotehrani","year":"2003","unstructured":"Khosrotehrani K, Johnson KL, Lau J, Dupuy A, Cha DH, Bianchi DW (2003) The influence of fetal loss on the presence of fetal cell microchimerism: a systematic review. Arthritis Rheum 48(11):3237\u20133247","journal-title":"Arthritis Rheum"},{"issue":"5","key":"5703_CR33","doi-asserted-by":"publisher","first-page":"504","DOI":"10.1016\/j.autrev.2018.03.006","volume":"17","author":"G Recalde","year":"2018","unstructured":"Recalde G, Moreno-Sosa T, Y\u00fadica F et al (2018) Contribution of sex steroids and prolactin to the modulation of T and B cells during autoimmunity. Autoimmun Rev 17(5):504\u2013512. https:\/\/doi.org\/10.1016\/j.autrev.2018.03.006","journal-title":"Autoimmun Rev"}],"container-title":["Rheumatology International"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00296-024-05703-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00296-024-05703-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00296-024-05703-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,9,13]],"date-time":"2024-09-13T02:08:18Z","timestamp":1726193298000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00296-024-05703-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,8,28]]},"references-count":33,"journal-issue":{"issue":"10","published-online":{"date-parts":[[2024,10]]}},"alternative-id":["5703"],"URL":"https:\/\/doi.org\/10.1007\/s00296-024-05703-4","relation":{},"ISSN":["1437-160X"],"issn-type":[{"value":"1437-160X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,8,28]]},"assertion":[{"value":"29 April 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 August 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 August 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"None.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"In compliance with ethical standards for publishing case reports, patient consent was obtained and documented prior to submission.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"Written informed consent was obtained from the patient before submission.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}}]}}